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Abstract
Introduction: Recent reports have highlighted the prevalence of vitamin D deficiency and suggested an
association with excess mortality in critically ill patients. Serum vitamin D concentrations in these studies were
measured following resuscitation. It is unclear whether aggressive fluid resuscitation independently influences
serum vitamin D.
Methods: Nineteen patients undergoing cardiopulmonary bypass were studied. Serum 25(OH)D3, 1a,25(OH)2D3,
parathyroid hormone, C-reactive protein (CRP), and ionised calcium were measured at five defined timepoints: T1 -
baseline, T2 - 5 minutes after onset of cardiopulmonary bypass (CPB) (time of maximal fluid effect), T3 - on return to the
intensive care unit, T4 - 24 hrs after surgery and T5 - 5 days after surgery. Linear mixed models were used to compare
measures at T2-T5 with baseline measures.
Results: Acute fluid loading resulted in a 35% reduction in 25(OH)D3 (59 ± 16 to 38 ± 14 nmol/L, P < 0.0001) and
a 45% reduction in 1a,25(OH)2D3 (99 ± 40 to 54 ± 22 pmol/L P < 0.0001) and i(Ca) (P < 0.01), with elevation in
parathyroid hormone (P < 0.0001). Serum 25(OH)D3 returned to baseline only at T5 while 1a,25(OH)2D3
demonstrated an overshoot above baseline at T5 (P < 0.0001). There was a delayed rise in CRP at T4 and T5; this
was not associated with a reduction in vitamin D levels at these time points.
Conclusions: Hemodilution significantly lowers serum 25(OH)D3 and 1a,25(OH)2D3, which may take up to 24 hours
to resolve. Moreover, delayed overshoot of 1a,25(OH)2D3 needs consideration. We urge caution in interpreting
serum vitamin D in critically ill patients in the context of major resuscitation, and would advocate repeating the
measurement once the effects of the resuscitation have abated.
Introduction
Vitamin D is synthesised in the skin through UV action
on 7-dehydrocholesterol, to cholecalciferol. It is trans-
ported in the blood by the Vitamin D binding protein
(VDBP) to the liver where it undergoes 25 hydroxylation
to form 25(OH)D3, which in turn undergoes 1a hydro-
xylation (especially, but not exclusively in the kidneys)
to form 1a,25(OH)2D3. Its traditionally recognised role
is to maintain adequate serum calcium and phosphate
levels, for bone mineralisation and optimal cardiac [1]
and skeletal muscle function [2]. However, increasing
data from biochemical, and molecular genetic studies
indicate that vitamin D has a much wider range of
actions, which are termed pleiotropic effects. These
include potentiation of antimicrobial action, and cardio-
protective and immunomodulatory effects [3]. The
immunomodulatory properties of vitamin D have been
shown to improve outcomes in transplant recipients [4],
reduce relapses in multiple sclerosis [5], and may reduce
the development of type I diabetes mellitus [6]. In the
general population there is a 26% increase in all-cause
mortality in those in the lowest quartile of 25 (OH)D3
levels when compared to the highest quartile [7].
Awareness of the pleiotropic effects of Vitamin D has
captured the interest of intensivists. Critically ill patients
with prolonged stays in an intensive care unit may
develop vitamin D deficiency for a number of reasons,
including lack of exposure to sunlight, malnutrition,
decreased renal 1a hydroxylation and increased tissue
conversion of 25(OH)D3 to 1a,25(OH)2D3 during acute
stress and the inflammatory response [8,9]. An addi-
tional contributor to vitamin D deficiency in critically ill
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patients may be perturbations in serum albumin and
VDBP. Reductions in serum concentrations of these
proteins will influence total circulating concentrations of
vitamin D [10]. Published data suggest a significantly
higher incidence of vitamin D deficiency and bone
resorption in chronically critically ill patients [11]. Van
den Berghe et al. [9] showed the levels of both 25(OH)
D3 and 1a,25(OH)2 D3 are low on admission to ICU
compared to age-matched controls. Evidence from a
recent case series [12] demonstrated significantly worse
outcomes for patients with reduced serum levels of 25
(OH)D3 in critical illness, although a direct causal effect
has not been proven. All this has generated renewed
interest in the pharmacodynamics of vitamin D, espe-
cially in the critically ill patient. This together with
accumulating evidence on hypovitaminosis D in the cri-
tically ill has prompted calls for supplementation in
these patients.
However, there are several limitations to the published
data. It is frequently unclear as to when the “baseline” mea-
surements were performed. Critically ill patients on admis-
sion to the hospital or intensive care unit often receive
large volumes of intravenous fluids to correct hypovolemia
and hypotension, and the extent of volume replacement is
often directly related to the severity of acute illness [13].
Acute expansion of the intravascular volume is associated
with reduction in levels of various electrolytes, proteins
and blood components due to hemodilution [14]. Whether
the post dilution effect would be responsible for the
observed low baseline levels of 25(OH)D3 needs investiga-
tion. Moreover, critically ill patients are often “water-
logged” and are slow in clearing body water. Consequently
any dilutional effect of baseline resuscitation may have an
impact on plasma concentrations beyond the resuscitation
period. How this will influence the interpretation of Vita-
min D in the peri-resuscitation period remains unclear.
Finally, most studies have examined 25(OH)D3 , while the
active hormone is 1a,25(OH)2D3. Whether changes in
1a,25(OH)2D3 parallel those of 25(OH)D3, during volume
loading and clearance also remain unknown. Of note, the
water-solubility and half-lives of these different forms of
vitamin D are quite different [15].
We chose cardiopulmonary bypass as a clinical model
to test this question. Patients undergoing routine elec-
tive cardiac surgery are not acutely unwell, and receive a
standard volume fluid load when going on to cardiopul-
monary bypass (CPB) which is cleared over the next
several days. They usually have a predictable course of
recovery and hence provide an ideal model to look at
the effects of acute fluid loading on vitamin D levels.
Materials and methods
This study was conducted at the Princess Alexandra
Hospital in Brisbane, a tertiary-care referral centre with
one of the biggest cardiac surgical services in Australia.
The study was approved by the institution’s Human
Research Ethics Committee and written, informed con-
sent was obtained from patients prior to inclusion.
Inclusion criteria
Patients aged 18 years or older scheduled to undergo
elective cardiac surgery under cardiopulmonary bypass
were eligible for enrolment into the study.
Patients were excluded from the study if they met any
of the following criteria: 1) if they were undergoing
urgent cardiac surgery, 2) if they had chronic hepatic dys-
function (grade greater than Child-Pugh A), 3) if they had
renal dysfunction (creatinine >200 micromol/L).
The conduct of anaesthesia and surgery was as per
standard practice. Briefly, the cardiopulmonary bypass
(CPB) circuit incorporated a membrane oxygenator
(Dideco Avante, Cellplex, Sorin, Mirondola, Italy) and
heart lung machine (Jostra HL 20, Maquet Critical Care
AB, Solna, Sweden). Pump rate was set at 2.4 L/minute/
m2 and temperature ranged from 32 to 35°C. The circuit
was primed with 2 L of Plasma-Lyte 148 (Na+ 140 mmol/
L, Cl- 98 mmol/L, K+ 5 mmol/L, Mg++ 1.5 mmol/L, Acet-
ate 27 mmol/L, Gluconate 23 mmol/L), a commercially
available balanced crystalloid solution. (Baxter Health-
care, Toongabbie, NSW, Australia).
Following surgery all patients were admitted to the
intensive care unit for 24 hours. They were all ventilated
postoperatively as per standard protocol. Vasoactive drugs
and external cardiac pacing were commenced according
to clinical need. In addition, all patients received stress
ulcer prophylaxis, analgesia, and anticoagulation prophy-
laxis with subcutaneous heparin and aspirin routinely
commenced the morning after their operation. Patients
were discharged from the ICU after 24 hours and from the
hospital between Day 5 and Day 7 postoperatively.
Fluid intake and output were recorded from the com-
mencement of surgery till discharge from the hospital;
these were done relative to a baseline value of zero litres
just prior to commencement of surgery. Patients were
weighed at baseline, 24 hours after surgery and on
Day 5.
Serum measurements
Blood was sampled at the following time points:
T1) Immediately before commencing cardio-pulmonary
bypass; T2) Five minutes after commencement of bypass,
prior to placement of the aortic cross-clamp (immediately
after a large increase in blood volume due to the mixture
with the CPB circuit prime); T3) On return to the inten-
sive care unit after surgery, T4) 24 hours after surgery,
T5) 5 days after surgery.
At each time point serum 25(OH)D3, 1 a,25(OH)2D3,
parathyroid hormone (PTH), total and ionised calcium,
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total magnesium and phosphate and C-reactive protein
were measured.
Assays
Serum 25(OH)D3 and 1a,25(OH)2D3 were measured by
LC MSMS system (Waters Corp Milford, MA, USA)
(between-run coefficient of variations (CV%): vitamin D2
at 42.0 nmol/L 5.9%, and at 91.0 nmol/L 7.7%; vitamin
D3 at 76.0 nmol/L 15.3%, and at 181 nmol/L 6.8%). Para-
thormone estimation was an immunoassay performed on
Siemens Immulite analyser (Siemens Healthcare Diag-
nostics, Medfield, MA, USA) with antibodies specific for
the C-terminal region thereby recognising only intact
PTH (between-run CV%: at 1.18 pmol/L 8.8%; at 6.69
pmol/L 5.3%, and at 42.87 pmol/L 5.0%, The total cal-
cium (Ca), magnesium (Mg2+) and inorganic phosphorus
(PO4
3-) were measured on Beckman DxC 800 general
chemistry analysers (Beckman Coulter Diagnostics, Full-
erton, CA, USA) by ion selective electrode, and photo-
metric methods (between-run precision limits: Ca at
1.98 mmol/L 1.7% and at 2.96 mmol/L 1.7%; Mg2+ at
0.75 mmol/L 3.8% and at 1.60 mmol/L 2.4%; PO4
3- at
0.98 mmol/L 5.1% and at 3.19 mmol/L 5.1%). The i(Ca)
was measured on Siemens Rapidlab 1265 blood gas ana-
lysers (Siemens Healthcare Diagnostics, Medfield, MA,
USA) by ion selective electrode (between-run CVs: at
0.80 mmol/L 1.8% and at 1.60 mmol/L 1.5%). CRP was
measured on Beckman DxC800 general chemistry analy-
sers using a turbidimetric method (between-run CVs: at
4.9 mg/L 5.3% and at 10.5 mg/L 3.6%).
Statistical methods
The data were analysed using SAS version 9.2 for
Windows (SAS Institute, Cary, NC, USA). Linear mixed
models were used to compare the measures of vitamin
D, electrolytes and CRP taken at time-points 2, 3, 4 and
5 with measures taken at baseline (time-point 1). In
separate analyses, the vitamin D measures were specified
as dependent variables in linear mixed models and then
tested for association with CRP, fluid balance and elec-
trolytes. R-square was used to express the magnitude of
correlation between the vitamin D measures and the
other parameters [16].
Results
Nineteen patients were included in the study. All
patients successfully underwent cardiac surgery and
were discharged live from the hospital. The baseline,
demographic and operative data are summarised in
Table 1.
Changes in fluid balance and body weight
Baseline values were taken as zero fluid balance status.
Predictably, there were positive fluid balances at T2
(3.5 ± 1.2 L), T3 (3.0 ± 1.5 L), and T4 (2.5 ± 1.2 L). On
Day 5, the fluid balance had started to return towards
baseline (1.1 ± 0.8 L). Changes in bodyweight followed
fluid balance profile. The mean bodyweight at baseline
was 88 ± 20 kg, increased to 91 ± 22 kg at T4 and
returned to 87 ± 21 kg at T5. All patients received at
least one dose of frusemide as part of routine postopera-
tive care. None of the patients received blood transfu-
sions during CPB.
Serum Vitamin D (25(OH)D3 and 1a,25(OH)2D3)
The mean baseline, serum 25(OH)D3 was 59 ± 16 nmol/
L. At T2, (immediately after mixture with the pump
prime), there was a 35% reduction in 25(OH)D3 to 38 ±
14 nmol/L (P < 0.0001). Serum 25(OH)D3 continued to
remain low and returned to baseline only on Day 5 (T5).
Serum 1a,25(OH)2D3 appeared to follow a similar
temporal course to that of 25(OH)D3 initially. The mean
baseline concentrations were 99 ± 40 pmol/L Hemodilu-
tion resulted in significant reductions (45%) in 1,25(OH)
2D3 to 54 ± 22 pmol/L (P < 0.0001). In contrast to
25(OH)D3, concentrations of 1 a,25(OH)2D3 demon-
strated a significant overshoot above baseline on Day 5
(T5) to 214 ± 91 pmol/L (P < 0.0001). These are illu-
strated graphically in Figure 1.
Serum PTH, calcium, magnesium and phosphate
Changes in serum PTH appeared to follow an opposite
course to that of 25(OH)D3 and 1a,25(OH)2D3. Baseline
levels (21 ± 19 pmol/L) were elevated, rose significantly
with hemodilution to 41 ± 25 pmol/L (P < 0.0001) and
returned to baseline at 24 hours and levels were signifi-
cantly low (5 ± 3 pmol/L) on Day 5. Changes in serum
ionised calcium, magnesium and phosphate are shown in
Table 2 and those of ionised calcium and PTH are shown
in Figure 2.
Serum CRP
Serum CRP levels were within the normal range at base-
line (6 ± 9 mg/L). There was a statistically significant
(but clinically insignificant) drop with hemodilution (4 ±
5 mg/L, P = 0.04). At 24 hours (T4) significant eleva-
tions in CRP with respect to baseline were noticed (82 ±
40 mg/L, P < 0.0001), and remained persistently elevated
even on Day 5 (134 ± 58 mg/L, P < 0.01).
Serum albumin and creatinine
The mean baseline serum albumin was 34 ± 4 g/L. At T2,
the concentrations fell by 30% to 24 ± 4 g/L (P < 0.0001),
followed by a gradual return towards baseline over the
following time points: T3 to 30 ± 4 G/L (P < 0.001), T4
to 32 ± 4 G/L (P = 0.11) and T5 32 ± 3 g/L (P = 0.06).
The mean baseline creatinine was 81 ± 22 μmol/L
(normal reference range <90 μmol/L), which fell to
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71 ± 16 μmol/L at T2 (P = 0.002). There was both a
clinically and a statistically insignificant overshoot
from baseline at T3, T4 and T5: 89 ± 38 μmol/L (P =
0.23), 90 ± 40 μmol/L (P = 0.15) and 90 ± 43 μmol/L
respectively (P = 0.2).
Effect of different variables on vitamin D
Using 25(OH)D3 as a dependent variable, linear mixed
models were used and tested for independent associa-
tion of changes in 25(OH)D3 with fluid balance, CRP
and electrolytes. Fluid balance showed a signifcant nega-
tive association with both 25(OH)D3 (effect size -4.9,
CI -6.4 to -3.4, P < 0.0001) and 1 a,25(OH)2D3 (effect
size -14.0, CI -22 to -6, P < 0.001). Changes in serum
albumin were strongly correlated with 25(OH)D3 (P <
0.0001) and 1a,25(OH)2D3 (P < 0.0002). Changes in
serum creatinine were correlated with 25(OH)D3, (P <
0.05), but not 1a,25(OH)2D3 (P = 0.94).
Serum CRP showed a significant positive association
with both 25(OH)D3 (effect size 0.08, 0.02 to 0.14, P <
0.01) and 1 a,25(OH)2D3 (effect size 0.62, CI 0.39 to
0.84), P < 0.0001).
Ionised calcium was strongly associated with both
25(OH)D3 (effect size 67.2 (CI 47.6 to 87, P < 0.0001)
and 1 a,25(OH)2D3 (effect size 249 (CI 127 to 371, P <
0.0001). Total calcium was also strongly associated with
both 25(OH)D3 (P < 0.0001) and 1 a,25(OH)2D3 (P <
0.0001). Phosphate concentrations did not show any sig-
nificant association with both 25(OH)D3 and 1 a,25(OH)
2D3 concentrations. Magnesium was less strongly asso-
ciated with 25(OH)D3 than calcium (P < 0.05).
There was no association between changes in fluid
balance and CRP (effect size -4.1, CI -11.3 to 3.1,
P = 0.26).
Classification of patient’s vitamin D status at various time
points
Table 3 illustrates the number of patients who would
have been classified as vitamin D insufficient or deficient
at various time points based on cut offs of 25(OH)D3 of
60 nmol/L and 30 nmol/L, respectively.
The individual patient’s endocrine data, calcium and
albumin concentrations at various time points with
changes in fluid balance at each of those time points are
supplied in a table form and available in Additional
file 1.
Discussion
The cardinal findings of the study are that intravascular
volume loading significantly affects both 25(OH)D3 and
1a,25(OH)2D3. Changes in 25(OH)D3 and 1a,25(OH)
2D3 were accompanied by reciprocal alterations in PTH
concentrations. Both volume shifts and inflammatory
response appeared to have independent effects on both
25(OH)D3 and 1a,25(OH)2D3 concentrations.
Changes in serum Vitamin D and PTH
Volume loading clearly appeared to impact on 25(OH)
D3 and 1a,25(OH)2D3 . At baseline, 25(OH)D3, was low
in keeping with the reported prevalence of hypovitami-
nosis D in the community.
On initiation of CPB, there was an increase in the cir-
culating blood volume by a volume of 2 L owing to the
obligatory addition of the pump prime. Assuming a nor-
mal blood volume of 5 L, this prime would increase the
blood volume by an additional 40%. Therefore, reduc-
tions of 25(OH)D3, and 1a,25(OH)2D3 of 35% and 45%
respectively at T2 would be consistent with this dilution
effect. Albumin binds to Vitamin D and, therefore,
reductions in albumin will be accompanied by parallel
reductions in the latter. Further support for this haemo-
dilution effect is shown by the strong correlation
between changes in serum albumin and vitamin D.
Other possible explanations include adsorption of vita-
min D by the plastic tubing and catabolism of these
hormones through 24-hydroxylation to calcitroic acid
Table 1 Demographic data
Total number of patients 19
Male/female distribution 14 M, 5 F
Mean age (yrs) 59 ± 12
Types of operations 7 CABG, 11 valvular procedures and
1 CABG + valve
Mean baseline creatinine
(micromol/L)
80 ± 22
Mean Baseline weight (kg) 88 ± 21
Mean BMI (kg/m2) 30 ± 6
Mean bypass time (min) 108 ± 49
Mean cross clamp time (min) 78 ± 45
BMI, body mass index; CABG, coronary artery bypass grafts.
Figure 1 An illustration of the changes in serum 25(OH)D3
(filled diamonds) and 1a,25(OH)2D3 (filled squares)
concentrations across the five time points.
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[17]. Another possibility to consider is a reduction in
serum VDBP concentrations from dilution as well
adsorption to plastic as it is a protein and, therefore,
may carry an electrical charge. However, the strong tem-
poral relationship of serum concentrations to hemodilu-
tion, the rapidity of the drop together with a subsequent
rise with fluid clearance and the magnitude of the drop
being explained by the proportional rise in circulating
volume argue in favour of a dilution effect as the pre-
ponderant cause. Plasma concentrations of these
hormones started to rise by T3. This is likely due to
intravascular volume losses owing to separation from
CPB, surgical losses and diuresis. Values only reached
baseline by 24 hours (T4) in the case of 1a,25(OH)2D3,
while statistically significant differences were still notice-
able for 25(OH)D3 at this time point.
At T5, 25(OH)D3 returned to baseline, while 1a,25
(OH)2D3 demonstrated a statistically significant over-
shoot from baseline. The mechanism of the delayed rise
in 1a,25(OH)2D3 is unclear. The most likely explanation
is the induction of 1- a hydroxylase by PTH. The rise in
PTH at T2 may be significant. PTH-dependent synthesis
of new 1- a hydroxylase takes several hours and it is
therefore likely that the initial rise in PTH was accom-
panied by a delayed rise in 1a,25(OH)2D3 [18].
Moreover, there was also evidence of inflammation as
evidenced by a delayed rise in CRP. Macrophages are
potent sources of 1- a hydroxylase and may also have
contributed to the elevated 1a,25(OH)2D3 levels through
extra renal production of 1a,25(OH)2D3 [19]. Alterations
in VDBP are known to influence monocyte responses to
25(OH)2D3 and 1a,25(OH)2D3 [20]. Whether it played a
role in the delayed rise in 1a,25(OH)2D3 remains specu-
lative. Support for the extra-renal contribution to the
delayed rise in 1a,25(OH)2D3 also comes from the lack
of a strong correlation between creatinine levels and
1a,25(OH)2D3. Other more chronic causes appear unli-
kely as the values were normal at baseline only five days
prior.
We also found that PTH levels further rose signifi-
cantly after commencement of CPB. The reduction in
ionised calcium as a result of hemodilution and chela-
tion by acetate-containing fluid used in priming the
CPB may be responsible for the rapid rise in PTH, as
part of the normal physiological response to hypocalcae-
mia. However, patients also had a significant and abrupt
increase in serum magnesium which acutely increases
PTH secretion. It is not possible in this model to distin-
guish between these stimuli for PTH secretion.
Clinical significance of our findings
To our knowledge this is the first study to examine the
effects of volume loading on serum vitamin D concen-
trations. Our data clearly demonstrate the impact of
fluid loading on serum vitamin D. Over the past decade,
some reports have highlighted the prevalence of vitamin
D deficiency and suggested an association with excess
mortality in critically ill patients [9,12]. Recently, Luci-
darme et al. identified a high prevalence of 25(OH)D3
Table 3 Proportion of patients who would have been
classified as Vitamin D insufficient or deficient at various
time points
T1 T2 T3 T4 T5
Vitamin D insufficiency (25(OH)D3
<60 nmol/L)
47% 89%* 68% 53% 47%
Vitamin D deficiency (25(OH)D3
<30 nmol/L)
5% 37%** 11% 11% 6%
*P < 0.01, significantly different from baseline.
**P < 0.05, significantly different from baseline.
T1 - baseline, T2 - five minutes after onset of cardiopulmonary bypass (CPB)
(time of maximal fluid effect), T3 - on return to the intensive care unit, T4 - 24
hrs after surgery, T5 - five days after surgery.
Figure 2 An illustration of the changes in serum PTH (filled
diamonds) and ionised calcium (filled squares) concentrations
across the five time points.
Table 2 Changes in serum total and ionised calcium, magnesium and phosphate
T1 T2 T3 T4 T5
Total calcium (mmol/L) 2.2 ± 0.1 1.9 ± 0.1* 2.1 ± 0.2* 2.1 ± 0.1* 2.3 ± 0.1*
i[Ca] (mmol/L) 1.1 ± 0.1 0.9 ± 0.1* 1.1 ± 0.1 1.1 ± 0.1 1.2 ± 0.04
Mg++ (mmol/L) 1.1 ± 0.4 1.3 ± 0.4 1.3 ± 0.2 1.1 ± 0.2 0.9 ± 0.1*
PO43- (mmol/L) 1.1 ± 0.2 0.9 ± 0.2* 1.0 ± 0.2* 1.2 ± 0.3 1.1 ± 0.3
*Significantly different from baseline (P < 0.01).T1 - baseline, T2 - five minutes after onset of cardiopulmonary bypass (CPB) (time of maximal fluid effect), T3 - on
return to the intensive care unit, T4 - 24 hrs after surgery, T5 - five days after surgery.
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insufficiency and deficiency in a prospective observa-
tional study of 134 critically ill patients [21]. They iden-
tified albumin, spring admission and SAPS II score as
predictors of hypovitaminosis but levels of 1a,25(OH)
2D3 were not estimated. More importantly, in none of
the above studies have the authors specified the timing
of blood sample collection in relationship to fluid resus-
citation. It is, therefore, unclear whether aggressive fluid
resuscitation may have influenced serum vitamin D con-
centrations. In Table 3 the data clearly illustrate the
potential for misclassification of patients as Vitamin D
insufficient or deficient purely from a fluid effect. More-
over, critically ill patients are often water logged and are
unable to clear a fluid load owing to hypoalbuminemia,
renal dysfunction, and high ADH levels. Consequently
any effects of a fluid load may be longstanding. In
patients with severe baseline deficiency such as 25(OH)
D3 values <15 nmol/L, it is likely that fluid loading may
not have a significant physiological impact. The distribu-
tion space of 25(OH)D3 is similar to that of plasma,
while 1a,25(OH)2D3 is closer to that of intracellular
water. Consequently the tonicity of the diluting fluid
and the resultant expansion of the intravascular and the
interstitial space become relevant. Based on our data, we
would urge caution in interpreting serum vitamin D in
critically ill patients in the context of major resuscitation
and would advocate repeating the measurement once
the effects of the resuscitation have abated. While not
examined in this study, another potential source of error
in assessing vitamin D status is the assay variability as
differences in vitamin D concentrations have been
reported on the same sample depending on the metho-
dology used [22].
Inflammatory response has been suggested to reduce
Vitamin D concentrations [9]. In this study, biochemical
evidence of inflammatory response began to emerge
only 24 hours after bypass in keeping with previously
published data; however this was accompanied by a rise
in 1a,25(OH)2D3 and there was a strong association
between CRP and 25(OH)D3 and 1a,25(OH)2D3.
Limitations of the study
Although the study is limited by the small sample size, the
effect size was large enough to produce significant results.
As stated earlier, the model of CPB was chosen because,
patients undergoing routine elective cardiac surgery are
not acutely unwell, hemodilution is an integral aspect of
cardiopulmonary bypass (CPB) which is cleared subse-
quently and these patients usually, have a predictable
course of recovery. Although the lower levels of patient
acuity and minimal organ dysfunction raise the question
whether these results can be transposed to other groups of
critically ill patients, we assert that acute physiological
effects of hemodilution are likely to be comparable across
various patient groups, although the magnitude of the
effect may be variable. As the protocol did not incorporate
measurements between Day 1 and Day 5, it was not possi-
ble to elucidate the mechanism behind delayed changes in
vitamin D concentrations. The measurement of VDBP
levels would have provided useful information in terms of
understanding of the mechanisms. CPB also initiates an
inflammatory response; however, this is often a delayed
process manifesting 12 to 24 hours after bypass (as
observed in this study), whilst the major volume changes
occurred soon after commencement of CPB. The early
changes are therefore likely to be due to volume effects.
Moreover, analysis of our data also showed that fluid shifts
correlated with changes in vitamin D but not CRP.
Conclusions
In conclusion, hemodilution and acute fluid shifts signifi-
cantly lower serum 25(OH)D3 and 1a,25(OH)2D3. These
may take up to 24 hours to resolve. The magnitude of
changes in 25(OH)D3 and 1a,25(OH)2D3 appeared to be
proportional to the extent of volume change. Based on
our data, we would urge caution in interpreting serum
vitamin D in critically ill patients in the context of major
resuscitation and would advocate repeating the measure-
ment once the effects of resuscitation have abated.
Key messages
• Acute fluid loading during critical illness markedly
reduces serum 25(OH)D3 and 1a,25(OH)2D3
concentrations.
• Serum concentrations may take up to 24 hours to
return to baseline.
• We urge caution in interpreting serum vitamin D
in critically ill patients in the context of major resus-
citation and would advocate repeating the measure-
ments once the effects of resuscitation have abated.
Additional material
Additional file 1: Additional tables. Table S1: Changes in individual
patients’ serum vitamin D, parathormone, calcium (total and ionised),
creatinine and albumin concentrations at various time points with
corresponding values for fluid balance. Table S2: Changes in patients’
creatinine, albumin, fluid balance and weight values at various time
points.
Abbreviations
CPB: Cardiopulmonary bypass; CRP: C-reactive protein; CA2+: serum total
calcium; [CA2+]: Serum ionised calcium; MG2+: serum magnesium; (PO4
3-):
Serum inorganic phosphorus; PTH: Parathormone; 25(OH)D3: 25-hydroxy
vitamin D3; 1a,25(OH)2D3: 1,25-dihydroxy vitamin D3.
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